Pentoxifylline for ulcerative colitis
Treatments studied
Part of Digestive system clinical trials.
This trial tests if the drug pentoxifylline can help people with mild to moderate ulcerative colitis. It may offer a new treatment option for those not on other strong medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have mild or moderate ulcerative colitis
- You are not currently taking steroids, immunosuppressants, or biological therapies
- You are not pregnant, breastfeeding, or planning to become pregnant during the study
- You do not have diabetes, colorectal cancer, serious liver or kidney problems
- You do not have a known allergy to pentoxifylline
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding the medicine pentoxifylline to standard care can help people with ulcerative colitis. It’s designed to see if this combination improves symptoms by changing inflammation.
This trial tests if a medication called nitazoxanide can help people with mild to moderate ulcerative colitis (UC). It may be a treatment option for those not already on strong UC medications.
This trial tests whether adding alpha lipoic acid (an antioxidant) to your usual mesalamine treatment helps control mild to moderate ulcerative colitis. It is for people newly diagnosed and not on other UC treatments.
This trial tests whether a natural compound called palmitoylethanolamide can help ulcerative colitis patients whose symptoms aren't controlled by standard medications. You'd be taking this alongside your current treatments to see if it reduces inflammation and symptoms.
This study tests adding a medicine called mebendazole (normally used for parasites) to standard mesalamine treatment for people with mild or moderate ulcerative colitis. The goal is to see if it helps control inflammation better than mesalamine alone.
This trial tests if adding febuxostat to your usual mesalamine treatment can help improve mild to moderate ulcerative colitis. It's for adults with confirmed UC who are not on steroids or other immune-suppressing drugs.
Hear when a new Inflammatory Bowel Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.